IBDEI0G4 ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16147,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16147,1,3,0)
 ;;=3^Coagulation Defect,Unspec
 ;;^UTILITY(U,$J,358.3,16147,1,4,0)
 ;;=4^D68.9
 ;;^UTILITY(U,$J,358.3,16147,2)
 ;;=^5002364
 ;;^UTILITY(U,$J,358.3,16148,0)
 ;;=E83.110^^64^776^3
 ;;^UTILITY(U,$J,358.3,16148,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16148,1,3,0)
 ;;=3^Hemochromatosis,Hereditary
 ;;^UTILITY(U,$J,358.3,16148,1,4,0)
 ;;=4^E83.110
 ;;^UTILITY(U,$J,358.3,16148,2)
 ;;=^339602
 ;;^UTILITY(U,$J,358.3,16149,0)
 ;;=D47.3^^64^776^6
 ;;^UTILITY(U,$J,358.3,16149,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16149,1,3,0)
 ;;=3^Hemorrhagic Thrombocythemia,Essential
 ;;^UTILITY(U,$J,358.3,16149,1,4,0)
 ;;=4^D47.3
 ;;^UTILITY(U,$J,358.3,16149,2)
 ;;=^5002258
 ;;^UTILITY(U,$J,358.3,16150,0)
 ;;=D69.1^^64^776^9
 ;;^UTILITY(U,$J,358.3,16150,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16150,1,3,0)
 ;;=3^Qualitative Platelet Defects
 ;;^UTILITY(U,$J,358.3,16150,1,4,0)
 ;;=4^D69.1
 ;;^UTILITY(U,$J,358.3,16150,2)
 ;;=^101922
 ;;^UTILITY(U,$J,358.3,16151,0)
 ;;=D69.6^^64^776^10
 ;;^UTILITY(U,$J,358.3,16151,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16151,1,3,0)
 ;;=3^Thrombocytopenia,Unspec
 ;;^UTILITY(U,$J,358.3,16151,1,4,0)
 ;;=4^D69.6
 ;;^UTILITY(U,$J,358.3,16151,2)
 ;;=^5002370
 ;;^UTILITY(U,$J,358.3,16152,0)
 ;;=I80.9^^64^776^8
 ;;^UTILITY(U,$J,358.3,16152,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16152,1,3,0)
 ;;=3^Phlebitis & Thrombophlebitis,Unspec Site
 ;;^UTILITY(U,$J,358.3,16152,1,4,0)
 ;;=4^I80.9
 ;;^UTILITY(U,$J,358.3,16152,2)
 ;;=^93357
 ;;^UTILITY(U,$J,358.3,16153,0)
 ;;=M31.1^^64^776^11
 ;;^UTILITY(U,$J,358.3,16153,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16153,1,3,0)
 ;;=3^Thrombotic Microangiopathy
 ;;^UTILITY(U,$J,358.3,16153,1,4,0)
 ;;=4^M31.1
 ;;^UTILITY(U,$J,358.3,16153,2)
 ;;=^119061
 ;;^UTILITY(U,$J,358.3,16154,0)
 ;;=D68.312^^64^776^1
 ;;^UTILITY(U,$J,358.3,16154,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16154,1,3,0)
 ;;=3^Antiphospholipid Antibody w/ Hemorrhagic Disorder
 ;;^UTILITY(U,$J,358.3,16154,1,4,0)
 ;;=4^D68.312
 ;;^UTILITY(U,$J,358.3,16154,2)
 ;;=^340503
 ;;^UTILITY(U,$J,358.3,16155,0)
 ;;=D68.318^^64^776^5
 ;;^UTILITY(U,$J,358.3,16155,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16155,1,3,0)
 ;;=3^Hemorrhagic Disorder d/t Circ Anticoag NEC
 ;;^UTILITY(U,$J,358.3,16155,1,4,0)
 ;;=4^D68.318
 ;;^UTILITY(U,$J,358.3,16155,2)
 ;;=^340504
 ;;^UTILITY(U,$J,358.3,16156,0)
 ;;=D68.311^^64^776^4
 ;;^UTILITY(U,$J,358.3,16156,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16156,1,3,0)
 ;;=3^Hemophilia,Acquired
 ;;^UTILITY(U,$J,358.3,16156,1,4,0)
 ;;=4^D68.311
 ;;^UTILITY(U,$J,358.3,16156,2)
 ;;=^340502
 ;;^UTILITY(U,$J,358.3,16157,0)
 ;;=Z51.89^^64^777^8
 ;;^UTILITY(U,$J,358.3,16157,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16157,1,3,0)
 ;;=3^Specified Aftercare Encounter
 ;;^UTILITY(U,$J,358.3,16157,1,4,0)
 ;;=4^Z51.89
 ;;^UTILITY(U,$J,358.3,16157,2)
 ;;=^5063065
 ;;^UTILITY(U,$J,358.3,16158,0)
 ;;=Z51.11^^64^777^1
 ;;^UTILITY(U,$J,358.3,16158,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16158,1,3,0)
 ;;=3^Antineoplastic Chemotherapy Encounter
 ;;^UTILITY(U,$J,358.3,16158,1,4,0)
 ;;=4^Z51.11
 ;;^UTILITY(U,$J,358.3,16158,2)
 ;;=^5063061
 ;;^UTILITY(U,$J,358.3,16159,0)
 ;;=Z71.3^^64^777^5
 ;;^UTILITY(U,$J,358.3,16159,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16159,1,3,0)
 ;;=3^Dietary Counseling & Surveillance
 ;;^UTILITY(U,$J,358.3,16159,1,4,0)
 ;;=4^Z71.3
 ;;^UTILITY(U,$J,358.3,16159,2)
 ;;=^5063245
 ;;^UTILITY(U,$J,358.3,16160,0)
 ;;=Z31.5^^64^777^6
 ;;^UTILITY(U,$J,358.3,16160,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16160,1,3,0)
 ;;=3^Genetic Counseling
 ;;^UTILITY(U,$J,358.3,16160,1,4,0)
 ;;=4^Z31.5
 ;;^UTILITY(U,$J,358.3,16160,2)
 ;;=^5062838
 ;;^UTILITY(U,$J,358.3,16161,0)
 ;;=Z71.89^^64^777^4
 ;;^UTILITY(U,$J,358.3,16161,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16161,1,3,0)
 ;;=3^Counseling,Other Spec
 ;;^UTILITY(U,$J,358.3,16161,1,4,0)
 ;;=4^Z71.89
 ;;^UTILITY(U,$J,358.3,16161,2)
 ;;=^5063253
 ;;^UTILITY(U,$J,358.3,16162,0)
 ;;=Z12.4^^64^777^3
 ;;^UTILITY(U,$J,358.3,16162,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16162,1,3,0)
 ;;=3^Cervical Cancer Screening
 ;;^UTILITY(U,$J,358.3,16162,1,4,0)
 ;;=4^Z12.4
 ;;^UTILITY(U,$J,358.3,16162,2)
 ;;=^5062687
 ;;^UTILITY(U,$J,358.3,16163,0)
 ;;=Z12.39^^64^777^2
 ;;^UTILITY(U,$J,358.3,16163,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16163,1,3,0)
 ;;=3^Breast Cancer Screening
 ;;^UTILITY(U,$J,358.3,16163,1,4,0)
 ;;=4^Z12.39
 ;;^UTILITY(U,$J,358.3,16163,2)
 ;;=^5062686
 ;;^UTILITY(U,$J,358.3,16164,0)
 ;;=Z12.12^^64^777^7
 ;;^UTILITY(U,$J,358.3,16164,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16164,1,3,0)
 ;;=3^Rectal Cancer Screening
 ;;^UTILITY(U,$J,358.3,16164,1,4,0)
 ;;=4^Z12.12
 ;;^UTILITY(U,$J,358.3,16164,2)
 ;;=^5062682
 ;;^UTILITY(U,$J,358.3,16165,0)
 ;;=C67.9^^64^778^2
 ;;^UTILITY(U,$J,358.3,16165,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16165,1,3,0)
 ;;=3^Malig Neop Bladder,Unspec
 ;;^UTILITY(U,$J,358.3,16165,1,4,0)
 ;;=4^C67.9
 ;;^UTILITY(U,$J,358.3,16165,2)
 ;;=^5001263
 ;;^UTILITY(U,$J,358.3,16166,0)
 ;;=D09.0^^64^778^1
 ;;^UTILITY(U,$J,358.3,16166,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16166,1,3,0)
 ;;=3^Carcinoma in Situ Bladder
 ;;^UTILITY(U,$J,358.3,16166,1,4,0)
 ;;=4^D09.0
 ;;^UTILITY(U,$J,358.3,16166,2)
 ;;=^267742
 ;;^UTILITY(U,$J,358.3,16167,0)
 ;;=C64.2^^64^778^5
 ;;^UTILITY(U,$J,358.3,16167,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16167,1,3,0)
 ;;=3^Malig Neop Kidney,Left,except Renal Pelvis
 ;;^UTILITY(U,$J,358.3,16167,1,4,0)
 ;;=4^C64.2
 ;;^UTILITY(U,$J,358.3,16167,2)
 ;;=^5001249
 ;;^UTILITY(U,$J,358.3,16168,0)
 ;;=C64.1^^64^778^6
 ;;^UTILITY(U,$J,358.3,16168,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16168,1,3,0)
 ;;=3^Malig Neop Kidney,Right,except Renal Pelvis
 ;;^UTILITY(U,$J,358.3,16168,1,4,0)
 ;;=4^C64.1
 ;;^UTILITY(U,$J,358.3,16168,2)
 ;;=^5001248
 ;;^UTILITY(U,$J,358.3,16169,0)
 ;;=C60.9^^64^778^7
 ;;^UTILITY(U,$J,358.3,16169,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16169,1,3,0)
 ;;=3^Malig Neop Penis,Unspec
 ;;^UTILITY(U,$J,358.3,16169,1,4,0)
 ;;=4^C60.9
 ;;^UTILITY(U,$J,358.3,16169,2)
 ;;=^5001229
 ;;^UTILITY(U,$J,358.3,16170,0)
 ;;=C61.^^64^778^8
 ;;^UTILITY(U,$J,358.3,16170,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16170,1,3,0)
 ;;=3^Malig Neop Prostate
 ;;^UTILITY(U,$J,358.3,16170,1,4,0)
 ;;=4^C61.
 ;;^UTILITY(U,$J,358.3,16170,2)
 ;;=^267239
 ;;^UTILITY(U,$J,358.3,16171,0)
 ;;=C65.1^^64^778^10
 ;;^UTILITY(U,$J,358.3,16171,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16171,1,3,0)
 ;;=3^Malig Neop Renal Pelvis,Right
 ;;^UTILITY(U,$J,358.3,16171,1,4,0)
 ;;=4^C65.1
 ;;^UTILITY(U,$J,358.3,16171,2)
 ;;=^5001251
 ;;^UTILITY(U,$J,358.3,16172,0)
 ;;=C65.2^^64^778^9
 ;;^UTILITY(U,$J,358.3,16172,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16172,1,3,0)
 ;;=3^Malig Neop Renal Pelvis,Left
 ;;^UTILITY(U,$J,358.3,16172,1,4,0)
 ;;=4^C65.2
 ;;^UTILITY(U,$J,358.3,16172,2)
 ;;=^5001252
 ;;^UTILITY(U,$J,358.3,16173,0)
 ;;=C62.11^^64^778^4
 ;;^UTILITY(U,$J,358.3,16173,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16173,1,3,0)
 ;;=3^Malig Neop Descended Testis,Right
 ;;^UTILITY(U,$J,358.3,16173,1,4,0)
 ;;=4^C62.11
 ;;^UTILITY(U,$J,358.3,16173,2)
 ;;=^5001234
 ;;^UTILITY(U,$J,358.3,16174,0)
 ;;=C62.12^^64^778^3
 ;;^UTILITY(U,$J,358.3,16174,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16174,1,3,0)
 ;;=3^Malig Neop Descended Testis,Left
 ;;^UTILITY(U,$J,358.3,16174,1,4,0)
 ;;=4^C62.12
 ;;^UTILITY(U,$J,358.3,16174,2)
 ;;=^5001235
 ;;^UTILITY(U,$J,358.3,16175,0)
 ;;=C62.91^^64^778^12
 ;;^UTILITY(U,$J,358.3,16175,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16175,1,3,0)
 ;;=3^Malig Neop Testis,Right
 ;;^UTILITY(U,$J,358.3,16175,1,4,0)
 ;;=4^C62.91
